These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3045321)

  • 81. Structure-Activity Relationships for the Marine Natural Product Sintokamides: Androgen Receptor N-Terminus Antagonists of Interest for Treatment of Metastatic Castration-Resistant Prostate Cancer.
    Yan L; Banuelos CA; Mawji NR; Patrick BO; Sadar MD; Andersen RJ
    J Nat Prod; 2021 Mar; 84(3):797-813. PubMed ID: 33124806
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis of nucleoside mono-, di-, and triphosphoramidates from solid-phase cyclosaligenyl phosphitylating reagents.
    Ahmadibeni Y; Tiwari RK; Sun G; Parang K
    Org Lett; 2009 May; 11(10):2157-60. PubMed ID: 19364114
    [TBL] [Abstract][Full Text] [Related]  

  • 83. QSAR of conformationally flexible molecules: comparative molecular field analysis of protein-tyrosine kinase inhibitors.
    Nicklaus MC; Milne GW; Burke TR
    J Comput Aided Mol Des; 1992 Oct; 6(5):487-504. PubMed ID: 1474396
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.
    Kruse CH; Holden KG; Pritchard ML; Feild JA; Rieman DJ; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1762-7. PubMed ID: 2970550
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
    Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
    Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
    Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
    J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inhibition of tyrosine protein kinases by the antineoplastic agent adriamycin.
    Donella-Deana A; Monti E; Pinna LA
    Biochem Biophys Res Commun; 1989 May; 160(3):1309-15. PubMed ID: 2543396
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2.
    Kruse CH; Holden KG; Offen PH; Pritchard ML; Feild JA; Rieman DJ; Bender PE; Ferguson B; Greig RG; Poste G
    J Med Chem; 1988 Sep; 31(9):1768-72. PubMed ID: 3045321
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibition of Abelson oncogene function by erbstatin analogues.
    Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
    Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Protein kinase inhibitors: the tyrosine-specific protein kinases.
    Lawrence DS; Niu J
    Pharmacol Ther; 1998 Feb; 77(2):81-114. PubMed ID: 9578319
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Protein kinase inhibitors: probes for the functions of protein phosphorylation.
    Casnellie JE
    Adv Pharmacol; 1991; 22():167-205. PubMed ID: 1835643
    [No Abstract]   [Full Text] [Related]  

  • 94. Rational design of enzyme inhibitors: multisubstrate analogue inhibitors.
    Broom AD
    J Med Chem; 1989 Jan; 32(1):2-7. PubMed ID: 2642553
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.